Citi, Jefferies Weigh In On Biogen Idec Amid Q3 Earnings

By: via Benzinga
Biogen Idec Inc (NASDAQ: BIIB) reported third quarter revenues of $2.5 billion and an EPS of $3.80. Following the report, a number of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.